Home > News > BioSante Pharmaceuticals To Present At Investor Conference
February 23rd, 2004
BioSante Pharmaceuticals To Present At Investor Conference
BioSante Pharmaceuticals announced today that Stephen M. Simes, its president and chief executive officer, is scheduled to present at the BIO CEO & Investor Conference at the Waldorf-Astoria Hotel in New York on Wednesday, February 25, at 9:30 a.m. EST. Mr. Simes will discuss BioSante's progress with its hormone therapy products and its nanotechnology-based drug and vaccine delivery systems.
Characterizing inkjet inks: Malvern Instruments presents new rheological research April 23rd, 2014
NanoSafe, Inc. announces the addition of the Labconco Protector® Glove Box to its NanoSafe Tested™ registry April 23rd, 2014
Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014
High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014